Iomeron 300 mg/ml inj. sol. i.thec./i.cavern./i.v./i.arter. vial 100 ml
Active ingredient: Iodine
View notice details →News topic
Active ingredient Iodine
Current shortage notices for the active ingredient Iodine, structured by product, country and reporting period.
8 noticesWhat the Iodine notices indicate for the supply chain
The 8 consolidated notices from Belgium are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.
GDP-capable pharmaceutical storage in Cheb
Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.
Iomeron 400 mg/ml inj. sol. i.v. vial 100 ml
Active ingredient: Iodine
View notice details →Iomeron 400 mg/ml inj. sol. i.v. vial 200 ml
Active ingredient: Iodine
View notice details →Iomeron 400 mg/ml inj. sol. i.v. vial 500 ml
Active ingredient: Iodine
View notice details →Iomeron 400 mg/ml inj. sol. i.v. vial 200 ml
Active ingredient: Iodine
View notice details →Iomeron 300 mg/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 100 ml
Active ingredient: Iodine
View notice details →Iomeron 400 mg/ml inj. opl. i.v. flac. 200 ml
Active ingredient: Iodine
View notice details →Iomeron 350 mg/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 500 ml
Active ingredient: Iodine
View notice details →